TABLE 2.
Drug | Infusion rate (mg/h) | Added drug (mg) | Eliminated drug (mg/9 h) | Drug removal (%) | CLADVOS [L/h] | CLCRRT [L/h] | |
---|---|---|---|---|---|---|---|
BFR 100 mL/min CFR 160 mL/min DFR 800 mL/min | BFR 200 mL/min CFR 320 mL/min DFR 800 mL/min | BFR 200 mL/h DFR 2 L/h | |||||
Anidulafungin | 5.1 | 63 | 38 | 61 | 0.84 | 0.84 | 0.02 |
Cefotaxime | 74.9 | 849 | 787 | 93 | 2.74 | 4.77 | 1.34 |
Daptomycin | 74 | 1,004 | 787 | 78 | 1.04 | 1.36 | 0.10 |
Fluconazole | 56 | 576 | 540 | 94 | 3.39 | 6.20 | 1.80 |
Ganciclovir | 23.7 | 262 | 246 | 94 | 2.91 | 5.88 | 1.98 |
Linezolid | 26.8 | 281 | 258 | 92 | 2.79 | 4.65 | 1.38 |
Meropenem | 59.2 | 595 | 556 | 93 | 3.40 | 6.08 | 1.96 |
Piperacillin | 164 | 1784 | 1,667 | 93 | 3.18 | 5.61 | 1.56 |
Residual CL (renal + non-renal) is neglected for calculation purposes. CRRT, clearance was calculated assuming a dialysate flow rate of 2 L/h. BFR: blood flow rate; CFR: concentrate flow rate; CL: clearance; CRRT: continuous renal replacement therapy; DFR: dialysate flow rate; grey shaded rows indicate drug with protein binding >90%.